
Early stage Preclinical Toxicity studies
Date: September 18, 2014
Service Description
MPI was contracted to run CV and Respiratory Safety Pharmacology as well as 28 day toxicity in two species.
What Went Well
There was excellent communication and problem solving skills by the MPI team. Issues were dealt with swiftly, professionally, and accurately.
What Could Be Improved
There was some oversensitivity on the PIs part due to lack of experience with a particular species reactions to treatment.
Lessons Learned from the Experience
Research the PIs background and experience first